If you work in a #sexualhealth clinic that provides #PrEP, please consider taking part in this short survey from @QMUL SHARE collective, as part of the Beyond The Clinic study bit.ly/40weNaX

a good time to remind folks that, if you aren’t having sex at the moment, you can take PrEP in an event based capacity when you know you are going to and then immediately start daily dosing again (if you’re going to be having sex again regularly). it’ll save you using pills you don’t need to!

Are you:
✅working in a UK sexual health service that provides #PrEP,
AND
✅willing to take part in a 15 minute survey?
We are conducting a brief survey of sexual health clinics for our #beyondtheclinic study. You can complete the survey here: bit.ly/40weNaX #studyparticipants

EMA recommends 13 new medicines for approval:
☑️ 1 medicine for #HIV-1 pre-exposure prophylaxis #PrEP to be taken twice a year
☑️ 1 medicine to treat patients with #Niemann-Pick type C
☑️ 1 medicine to be taken orally to treat hereditary angioedema #HAE

www.ema.europa.eu/en/news/meet...
#PublicHealth

This is a study I'm working on for
@shareeastlondon.bsky.social
- please share, and if you're a sexual health clinician - please fill it out! There's more info about the study here: shareresearch.org.uk/beyond-the-c... #beyondtheclinic

Our latest study to understand the perspective of people living with HIV in Europe is now live!

We created it together with an amazing steering group of community members from 17 countries.

Please do the survey if you are living with HIV in UK and Europe and SHARE widely !! 🙏🙏🙏🙏

"We must say, loudly and consistently, that what is happening is entirely unacceptable. Our ethical obligations do not vary according to the whims of politicians. We must not remain silent".

Excellent piece by @martinmckee.bsky.social & @bachynski.bsky.social

International healthcare workers’ experiences and perceptions of the 2022 multi-country mpox outbreak In May 2022, the most widespread outbreak of sustained transmission of mpox outside of countries historically affected countries in Western and Central Africa occurred. We aimed to examine the persona...

In these unthinkably dark days for global public health I’m proud to share the results of this international survey which describes the challenging and distressing experiences of clinicians in 12 countries during the 2022/23 #mpox pandemic.

eur01.safelinks.protection.outlook.com?url=https%3A...

🚨@sophiaforum.bsky.social are recruiting for a community researcher to work on a study in partnership with @shareeastlondon.bsky.social (where I work!) Check out the job ad on LinkedIn: www.linkedin.com/jobs/view/41...

“If that would have lessened my symptoms, that would have been great...”: a qualitative study about the acceptability of tecovirimat as treatment for mpox - BMC Medicine Background Tecovirimat, an antiviral treatment for smallpox, was approved as a treatment for mpox by the European Medicines Agency in January 2022. Approval was granted under “exceptional circumstance...

Excited to share a new research paper (open access) from our collaboration with @thelovetankcic.bsky.social and the HIV/STI and Emergency Preparedness teams at @who.int.bsky.social

doi.org/10.1186/s129...

It’s day three of our #5DaysOfAction as we approach #WorldAIDSDay 2024.

Help us combat misinformation about HIV and raise awareness of World AIDS Day by sharing our 5 facts about HIV post on social media.

Repost and share with your networks!